- Home
- EBS vs SOR Comparison
EBS vs SOR Comparison
Compare EBS & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- SOR
- Stock Information
- Founded
- EBS 1998
- SOR 1968
- Country
- EBS United States
- SOR United States
- Employees
- EBS N/A
- SOR N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- SOR Investment Managers
- Sector
- EBS Health Care
- SOR Finance
- Exchange
- EBS Nasdaq
- SOR Nasdaq
- Market Cap
- EBS 393.9M
- SOR 328.9M
- IPO Year
- EBS 2006
- SOR N/A
- Fundamental
- Price
- EBS $5.04
- SOR $41.75
- Analyst Decision
- EBS Strong Buy
- SOR
- Analyst Count
- EBS 3
- SOR 0
- Target Price
- EBS $14.33
- SOR N/A
- AVG Volume (30 Days)
- EBS 1.2M
- SOR 16.2K
- Earning Date
- EBS 05-07-2025
- SOR 01-01-0001
- Dividend Yield
- EBS N/A
- SOR 7.24%
- EPS Growth
- EBS N/A
- SOR N/A
- EPS
- EBS N/A
- SOR 6.50
- Revenue
- EBS $1,043,600,000.00
- SOR N/A
- Revenue This Year
- EBS N/A
- SOR N/A
- Revenue Next Year
- EBS $19.88
- SOR N/A
- P/E Ratio
- EBS N/A
- SOR $6.41
- Revenue Growth
- EBS N/A
- SOR N/A
- 52 Week Low
- EBS $1.82
- SOR $36.41
- 52 Week High
- EBS $15.10
- SOR $42.75
- Technical
- Relative Strength Index (RSI)
- EBS 48.72
- SOR 47.83
- Support Level
- EBS $4.13
- SOR $39.55
- Resistance Level
- EBS $4.69
- SOR $41.10
- Average True Range (ATR)
- EBS 0.35
- SOR 1.32
- MACD
- EBS 0.15
- SOR 0.04
- Stochastic Oscillator
- EBS 94.91
- SOR 53.87
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.